Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?
Morton
Colin A
CA
Department of Dermatology, Falkirk Royal Infirmary, Falkirk, Scotland, UK.
D000287:Administration, Topical; D000622:Aminolevulinic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D001913:Bowen's Disease / Q000188:drug therapy*; D017679:Cryotherapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D010778:Photochemotherapy / Q000295:instrumentation / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D017319:Photosensitizing Agents; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid; D005472:Fluorouracil